Dis‑Chem's FY2026 Mixed as Revenue Climbs, Earnings Dip
Dis‑Chem CEO Rui Morais unpacks a results set showing strong revenue growth but pressure on headline earnings. He explains the Group’s R445m investment into its healthcare ecosystem, the performance of Better Rewards, margin pressure in dispensary and wholesale, and how the Store of the Future will reshape customer experience and profitability. Kaya FM
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.